Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum

Neurosci Lett. 2011 Aug 15;500(2):139-43. doi: 10.1016/j.neulet.2011.06.021. Epub 2011 Jun 17.

Abstract

An increasing large body of research on Parkinson's disease (PD) has focused on the understanding of the mechanisms behind the potential neuro protection offered by antioxidants and iron chelating agents. In this study, the protective effect of the bioflavonoid quercetin on 6-hydroxydopamine (6-OHDA)-induced model of PD was investigated. PD was induced by a single intracisternal injection of 6-hydroxydopamine (300μg) to male Sprague-Dawley rats. Quercetin treatment (30mg/kg body weight) over 14 consecutive days markedly increased the striatal dopamine and antioxidant enzyme levels compared with similar measurements in the group treated with 6-OHDA alone. There was a significant decrease in protein carbonyl content in the striatum compared with that of rats that did not receive quercetin. A significant increase in neuronal survivability was also found with quercetin treatment in rats administered 6-OHDA. In conclusion, treatment with quercetin defended against the oxidative stress in the striatum and reduced the dopaminergic neuronal loss in the rat model of PD.

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cell Survival / drug effects
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Glutathione / metabolism
  • Lipid Peroxides / metabolism
  • Male
  • Neurons / drug effects
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects*
  • Oxidopamine*
  • Parkinson Disease / etiology
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology
  • Protein Carbonylation / drug effects
  • Quercetin / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Biomarkers
  • Lipid Peroxides
  • Neuroprotective Agents
  • Oxidopamine
  • Quercetin
  • Glutathione